Literature DB >> 6330548

Evidence for disordered control of 1,25-dihydroxyvitamin D production in absorptive hypercalciuria.

A E Broadus, K L Insogna, R Lang, A F Ellison, B E Dreyer.   

Abstract

In previous studies, we observed increases in the circulating concentration and production rate of 1,25-dihydroxyvitamin D (1,25-(OH)2D) in a large majority of patients with the syndrome of absorptive hypercalciuria. In the present study, the hypothesis that 1,25-(OD)2D production might be relatively autonomous in this syndrome was tested by fashioning a suppression test in which patients were challenged with a short-term increase in dietary calcium intake. We found that contrary to our hypothesis, the circulating concentration of 1,25-(OH)2D was remarkably sensitive to calcium intake in 15 patients with absorptive hypercalciuria (mean decrease, from 74 to 49 pg per milliliter, P less than 0.001). When this challenge was prolonged for two weeks, however, patients with absorptive hypercalciuria had evidence of an apparent "escape" phenomenon, in which the circulating concentration of 1,25-(OH)2D rebounded toward its initial level and the renal tubular phosphate threshold fell markedly. These findings provide evidence for disordered control of renal phosphate handling and 1,25-(OH)2D production in absorptive hypercalciuria and suggest a linked rather than a cause-and-effect relation between these two abnormalities.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6330548     DOI: 10.1056/NEJM198407123110201

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  35 in total

Review 1.  Genes in idiopathic calcium oxalate stone disease.

Authors:  H O Goodman; R Brommage; D G Assimos; R P Holmes
Journal:  World J Urol       Date:  1997       Impact factor: 4.226

Review 2.  Bone disease and idiopathic hypercalciuria.

Authors:  Joseph E Zerwekh
Journal:  Semin Nephrol       Date:  2008-03       Impact factor: 5.299

Review 3.  Environmental factors in the pathophysiology of recurrent idiopathic calcium urolithiasis (RCU), with emphasis on nutrition.

Authors:  P O Schwille; U Herrmann
Journal:  Urol Res       Date:  1992

4.  Involvement of low-calcium diet in the reduced bone mineral content of idiopathic renal stone formers.

Authors:  M Fuss; T Pepersack; J Van Geel; J Corvilain; J C Vandewalle; P Bergmann; J Simon
Journal:  Calcif Tissue Int       Date:  1990-01       Impact factor: 4.333

5.  Expression of fibroblast growth factor 23, vitamin D receptor, and sclerostin in bone tissue from hypercalciuric stone formers.

Authors:  Viviane Barcellos Menon; Rosa Maria Affonso Moysés; Samirah Abreu Gomes; Aluizio Barbosa de Carvalho; Vanda Jorgetti; Ita Pfeferman Heilberg
Journal:  Clin J Am Soc Nephrol       Date:  2014-04-24       Impact factor: 8.237

Review 6.  Vitamin D-endocrine system.

Authors:  N H Bell
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

7.  Relationship between Urinary Calcium and Bone Mineral Density in Patients with Calcium Nephrolithiasis.

Authors:  Khashayar Sakhaee; Naim M Maalouf; John Poindexter; Beverley Adams-Huet; Orson W Moe
Journal:  J Urol       Date:  2017-01-05       Impact factor: 7.450

Review 8.  Urolithiasis in children: current medical management.

Authors:  J Laufer; H Boichis
Journal:  Pediatr Nephrol       Date:  1989-07       Impact factor: 3.714

Review 9.  Bone mineral content in calcium renal stone formers.

Authors:  A Trinchieri
Journal:  Urol Res       Date:  2005-08-03

10.  Mechanism of hypercalciuria in genetic hypercalciuric rats. Inherited defect in intestinal calcium transport.

Authors:  D A Bushinsky; M J Favus
Journal:  J Clin Invest       Date:  1988-11       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.